Statistics
Publications
2
Citations
63
H-Index
2
Active since
2015
Affiliations
N. Holtermann is an author at Ludwig-Maximilians-Universität München specializing in cancer pharmacology, pharmacology, and therapeutic tyrosine kinase inhibitors.
Publications per year
2015–2016
2
2
Masitinib monotherapy in canine epitheliotropic lymphoma
N. Holtermann, Matti Kiupel, Martin Kessler et al. · Veterinary and Comparative Oncology · 2015 · 31 citations · Full text
Medicine, Oncology, Pharmacology +13
1–2 of 2